Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 54, 2020 - Issue 1
Journal homepage
93
Views
0
CrossRef citations to date
0
Altmetric
Articles

Impact of biparametric prebiopsy prostate magnetic resonance imaging on the diagnostics of clinically significant prostate cancer in biopsy naïve men

Juha KnaapilaDepartment of Urology, University of Turku and Turku University Hospital, Turku, Finland; ;Department of Surgery, Satakunta Central Hospital, Pori, Finland; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-0997-9668
ORCID Icon,
Venla AutioDepartment of Urology, University of Turku and Turku University Hospital, Turku, Finland;
,
Ivan JamborDepartment of Diagnostic Radiology, University of Turku, Turku, Finland; ;Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; ;Medical Imaging Centre of Southwest Finland, Turku University Hospital, Turku, Finland;
,
Otto EttalaDepartment of Urology, University of Turku and Turku University Hospital, Turku, Finland;
,
Janne VerhoDepartment of Diagnostic Radiology, University of Turku, Turku, Finland; ;Medical Imaging Centre of Southwest Finland, Turku University Hospital, Turku, Finland;
,
Aida KiviniemiDepartment of Diagnostic Radiology, University of Turku, Turku, Finland; ;Medical Imaging Centre of Southwest Finland, Turku University Hospital, Turku, Finland; ORCID Iconhttp://orcid.org/0000-0002-5376-8270
ORCID Icon,
Pekka TaimenInstitute of Biomedicine, University of Turku, Turku, Finland; ;Department of Pathology, Turku University Hospital, Turku, Finland;
,
Ileana Montoya PerezDepartment of Diagnostic Radiology, University of Turku, Turku, Finland; ;Department of Future Technologies, University of Turku, Turku, Finland
,
Hannu J. AronenDepartment of Diagnostic Radiology, University of Turku, Turku, Finland; ;Medical Imaging Centre of Southwest Finland, Turku University Hospital, Turku, Finland;
,
Kari T. SyvänenDepartment of Urology, University of Turku and Turku University Hospital, Turku, Finland;
&
Peter J. BoströmDepartment of Urology, University of Turku and Turku University Hospital, Turku, Finland;
show all
Pages 7-13 | Received 20 Aug 2019, Accepted 25 Dec 2019, Published online: 09 Jan 2020

References

  • Epstein JI, Zelefsky MJ, Sjoberg DD, et al. A contemporary prostate cancer grading system: a validated alternative to the Gleason score. Eur Urol. 2016;69:428–435.
  • Berney DM, Beltran L, Fisher G, et al. Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome. Br J Cancer. 2016;114:1078–1083.
  • Mottet N, van den Bergh RCN, Briers E, et al. European association of urology guidelines. 2018 ed. Presented at the EAU Annual Congress Copenhagen 2018. Arnhem, The Netherlands: European Association of Urology Guidelines Office; 2018.
  • Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389:815–822.
  • Epstein JI, Feng Z, Trock BJ, et al. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades. Eur Urol. 2012;61:1019–1024.
  • Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review of complications of prostate biopsy. Eur Urol. 2013;64:876–892.
  • Knaapila J, Gunell M, Syvänen K, et al. Prevalence of complications leading to a health care contact after transrectal prostate biopsies: a prospective, controlled, multicenter study based on a selected study cohort. Eur Urol Focus. 2017;5:443–448.
  • Lahdensuo K, Rannikko A, Anttila VJ, et al. Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005–2013: a population-based analysis. Prostate Cancer Prostatic Dis. 2016;19:417–422.
  • Moldovan PC, Van den Broeck T, Sylvester R, et al. What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the European Association of urology prostate cancer guidelines panel. Eur Urol. 2017;72:250–266.
  • Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018;378:1767–1777.
  • Drost FH, Osses DF, Nieboer D, et al. Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev. 2019;4:CD012663.
  • Rouvière O, Puech P, Renard-Penna R, et al. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol. 2019;20:100–109.
  • van der Leest M, Cornel E, Israël B, et al. Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: a large prospective multicenter clinical study. Eur Urol. 2019;75:570–578.
  • Epstein JI, Egevad L, Amin MB, et al. The 2014 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic Carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40:244–252.
  • Monda SM, Vetter JM, Andriole GL, et al. Cognitive versus software fusion for MRI targeted biopsy: experience before and after implementation of fusion. Urology. 2018;119:115–120.
  • Wegelin O, Exterkate L, van der Leest M, et al. The FUTURE trial: a multicenter randomised controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with prior negative biopsies. Eur Urol. 2019;75:582–590.
  • Xu N, Wu YP, Li XD, et al. Risk of upgrading from prostate biopsy to radical prostatectomy pathology: is magnetic resonance imaging-guided biopsy more accurate? J Cancer. 2018;9:3634–3639.
  • Borkowetz A, Platzek I, Toma M, et al. Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy. BJU Int. 2016;118:213–220.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.